Journal of the American Society of Hypertension
Volume 4, Issue 4 , Pages 196-202 , July 2010

Urinary albumin excretion among nondipper hypertensive patients is closely related with the pattern of nondipping

  • Baris Afsar, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Baris Afsar, MD, Mesrutiyet Mah, Mustafa türkcelik Sok, Büsra Sitesi C Blok, Zonguldak, 67100, Turkey. Tel: + 90 (372) 251 46 26; fax: + 90 (372) 252 19 23.
    • ,
  • Rengin Elsurer, MD

Received 11 May 2010 ,Accepted 15 June 2010.

References 

  1. Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis. 2006;47:927–946
  2. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35:898–903
  3. Boulatov VA, Stenehjem A, Os I. Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension. Am J Hypertens. 2001;14:338–344
  4. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: a Genoa investigation on complications. Hypertension. 1997;30:1135–1143
  5. Palatini P, Graniero GR, Canali C, Santonastaso M, Mos L, Piccolo D, et al. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hypertens. 1995;13:1796–1800
  6. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens. 1994;12:947–953
  7. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet. 1974;1:1190–1192
  8. Gerber LM, Shmukler C, Alderman MH. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch Intern Med. 1992;152:373–377
  9. Høegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension. 1994;24:101–105
  10. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 1992;61:94–97
  11. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens. 1989;2:259–261
  12. James MA, Fotherby MD, Potter JF. Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure. Clin Sci (Lond). 1995;88:185–190
  13. Hörner D, Fliser D, Klimm HP, Ritz E. Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens. 1996;14:655–660
  14. Pedrinelli R, Lindpaintner K, Dell'Omo G, Napoli V, Di Bello V, De Caterina R, et al. Urinary albumin excretion and atherosclerosis in essential hypertension. Clin Sci (Lond). 1997;92:45–50
  15. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;2:530–533
  16. Pontremoli R, Cheli V, Sofia A, Tirotta A, Ravera M, Nicolella C, et al. Relavence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant. 1995;10(Suppl 6):6–9
  17. James MA, Fotherby MD, Potter JF. Microalbuminuria in elderly hypertensives: reproducibility and relation to clinic and ambulatory blood pressure. J Hypertens. 1994;12:309–314
  18. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens. 1997;11:727–732
  19. West JN, Gosling P, Dimmitt SB, Littler WA. Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci (Lond). 1991;81:373–377
  20. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994;7:23–29
  21. Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Rocanova JI, et al. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control. J Hypertens. 2000;18:803–809
  22. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens. 2000;18:645–654
  23. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens. 1996;9:334–341
  24. Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Lalanne P, Marre M, et al. Loss of the nocturnal decline in blood pressure in subjects with essential hypertension and microalbuminuria. Blood Press Monit. 1996;1:469–473
  25. Tsioufis C, Antoniadis D, Stefanadis C, Tzioumis K, Pitsavos C, Kallikazaros I, et al. Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens. 2002;15:600–604
  26. Nakano S, Ito T, Furuya K, Tsuda S, Konishi K, Nishizawa M, et al. Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects. Hypertens Res. 2004;27:647–656
  27. Parving HH. Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens Suppl. 1996;14:S89–S93
  28. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J. 1989;118:782–795
  29. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344:14–18
  30. Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension. 1993;21:810–815
  31. Pedersen EB, Mogensen CE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest. 1976;36:231–237
  32. Nishimura M, Uzu T, Fujii T, Kimura G. Disturbed circadian rhythm of urinary albumin excretion in nondipper type of essential hypertension. Am J Nephrol. 2002;22:455–462

 Conflict of interest: none.

PII: S1933-1711(10)00123-3

doi: 10.1016/j.jash.2010.06.004

Journal of the American Society of Hypertension
Volume 4, Issue 4 , Pages 196-202 , July 2010

Article Tools

* Image Usage & Resolution